These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8163993)

  • 1. Motor neuron disease in a defined English population: estimates of incidence and mortality.
    Dean G; Quigley M; Goldacre M
    J Neurol Neurosurg Psychiatry; 1994 Apr; 57(4):450-4. PubMed ID: 8163993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
    Goldacre MJ; Duncan M; Griffith M; Turner MR
    J Neurol; 2010 May; 257(5):706-15. PubMed ID: 19946783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality from motor neuron disease in the province of Bologna, Italy, 1986 through 1988.
    Ferro S; Giovannini A; Fiorani L; Carmentano P; D'Alessandro R
    Arch Neurol; 1992 Jun; 49(6):661-3. PubMed ID: 1596203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neuron disease in England and Wales, 1959-1979.
    Buckley J; Warlow C; Smith P; Hilton-Jones D; Irvine S; Tew JR
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):197-205. PubMed ID: 6842228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital admission for acute pancreatitis in an English population, 1963-98: database study of incidence and mortality.
    Goldacre MJ; Roberts SE
    BMJ; 2004 Jun; 328(7454):1466-9. PubMed ID: 15205290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
    Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
    J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The falling rates of hospital admission, case fatality, and population-based mortality for subarachnoid hemorrhage in England, 1999-2010.
    Mukhtar TK; Molyneux AJ; Hall N; Yeates DR; Goldacre R; Sneade M; Clarke A; Goldacre MJ
    J Neurosurg; 2016 Sep; 125(3):698-704. PubMed ID: 26722856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in mortality for motor neuron disease in Italy, 1980-1999].
    Altavista P; Belli S; Binazzi A; Comba P; Mastrantonio M; Uccelli R; Vanacore N
    Epidemiol Prev; 2006; 30(2):108-13. PubMed ID: 16909959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture.
    Fong KY; Yu YL; Chan YW; Kay R; Chan J; Yang Z; Kwan MC; Leung KP; Li PC; Lam TH; Cheung RT
    Neuroepidemiology; 1996; 15(5):239-45. PubMed ID: 8878076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising mortality from motor neurone disease: an explanation.
    Neilson S; Robinson I; Clifford Rose F; Hunter M
    Acta Neurol Scand; 1993 Mar; 87(3):184-91. PubMed ID: 8475687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in mortality rates for death-certificate-coded diabetes mellitus in an English population 1979-99.
    Goldacre MJ; Duncan ME; Cook-Mozaffari P; Neil HA
    Diabet Med; 2004 Aug; 21(8):936-9. PubMed ID: 15270802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide incidence of motor neuron disease using the French health insurance information system database.
    Kab S; Moisan F; Preux PM; Marin B; Elbaz A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
    Elian M; Dean G
    Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975 - 2004.
    Day TG; Scott M; Perring R; Doyle P
    Amyotroph Lateral Scler; 2007 Dec; 8(6):337-42. PubMed ID: 18033591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the cohort effect on the trend in mortality from motor neuron disease in Spain, 19551-1002].
    Llorca Díaz J; Prieto Salceda MD; Delgado-Rodríguez M
    Rev Esp Salud Publica; 1999; 73(4):481-8. PubMed ID: 10575936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality from heart failure in an English population, 1979-2003: study of death certification.
    Goldacre MJ; Mant D; Duncan M; Griffith M
    J Epidemiol Community Health; 2005 Sep; 59(9):782-4. PubMed ID: 16100317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy.
    Ragonese P; Salemi G; Aridon P; Conte S; Cuccia G; Lupo I; Savettieri G
    Neuroepidemiology; 2002; 21(3):148-52. PubMed ID: 12006778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.